Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CIS Insulin Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Long-Acting Analog
1.2.3 Rapid Acting Analog
1.2.4 Premixed Analog
1.2.5 Intermediate Insulin
1.2.6 Short Acting Insulin
1.2.7 Premixed Insulin
1.3 Market by Application
1.3.1 Global CIS Insulin Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Type I and Other Diabetes
1.3.3 Type II Diabetes
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global CIS Insulin Market Perspective (2018-2033)
2.2 CIS Insulin Growth Trends by Region
2.2.1 Global CIS Insulin Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 CIS Insulin Historic Market Size by Region (2018-2023)
2.2.3 CIS Insulin Forecasted Market Size by Region (2024-2033)
2.3 CIS Insulin Market Dynamics
2.3.1 CIS Insulin Industry Trends
2.3.2 CIS Insulin Market Drivers
2.3.3 CIS Insulin Market Challenges
2.3.4 CIS Insulin Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top CIS Insulin Players by Revenue
3.1.1 Global Top CIS Insulin Players by Revenue (2018-2023)
3.1.2 Global CIS Insulin Revenue Market Share by Players (2018-2023)
3.2 Global CIS Insulin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by CIS Insulin Revenue
3.4 Global CIS Insulin Market Concentration Ratio
3.4.1 Global CIS Insulin Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CIS Insulin Revenue in 2022
3.5 CIS Insulin Key Players Head office and Area Served
3.6 Key Players CIS Insulin Product Solution and Service
3.7 Date of Enter into CIS Insulin Market
3.8 Mergers & Acquisitions, Expansion Plans
4 CIS Insulin Breakdown Data by Type
4.1 Global CIS Insulin Historic Market Size by Type (2018-2023)
4.2 Global CIS Insulin Forecasted Market Size by Type (2024-2033)
5 CIS Insulin Breakdown Data by Application
5.1 Global CIS Insulin Historic Market Size by Application (2018-2023)
5.2 Global CIS Insulin Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America CIS Insulin Market Size (2018-2033)
6.2 North America CIS Insulin Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America CIS Insulin Market Size by Country (2018-2023)
6.4 North America CIS Insulin Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe CIS Insulin Market Size (2018-2033)
7.2 Europe CIS Insulin Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe CIS Insulin Market Size by Country (2018-2023)
7.4 Europe CIS Insulin Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific CIS Insulin Market Size (2018-2033)
8.2 Asia-Pacific CIS Insulin Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific CIS Insulin Market Size by Region (2018-2023)
8.4 Asia-Pacific CIS Insulin Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America CIS Insulin Market Size (2018-2033)
9.2 Latin America CIS Insulin Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America CIS Insulin Market Size by Country (2018-2023)
9.4 Latin America CIS Insulin Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa CIS Insulin Market Size (2018-2033)
10.2 Middle East & Africa CIS Insulin Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa CIS Insulin Market Size by Country (2018-2023)
10.4 Middle East & Africa CIS Insulin Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Eli Lilly
11.1.1 Eli Lilly Company Detail
11.1.2 Eli Lilly Business Overview
11.1.3 Eli Lilly CIS Insulin Introduction
11.1.4 Eli Lilly Revenue in CIS Insulin Business (2018-2023)
11.1.5 Eli Lilly Recent Development
11.2 Novo Nordisk
11.2.1 Novo Nordisk Company Detail
11.2.2 Novo Nordisk Business Overview
11.2.3 Novo Nordisk CIS Insulin Introduction
11.2.4 Novo Nordisk Revenue in CIS Insulin Business (2018-2023)
11.2.5 Novo Nordisk Recent Development
11.3 Takeda Pharmaceuticals
11.3.1 Takeda Pharmaceuticals Company Detail
11.3.2 Takeda Pharmaceuticals Business Overview
11.3.3 Takeda Pharmaceuticals CIS Insulin Introduction
11.3.4 Takeda Pharmaceuticals Revenue in CIS Insulin Business (2018-2023)
11.3.5 Takeda Pharmaceuticals Recent Development
11.4 Sanofi Aventis
11.4.1 Sanofi Aventis Company Detail
11.4.2 Sanofi Aventis Business Overview
11.4.3 Sanofi Aventis CIS Insulin Introduction
11.4.4 Sanofi Aventis Revenue in CIS Insulin Business (2018-2023)
11.4.5 Sanofi Aventis Recent Development
11.5 Nanjing Xinbai Pharmaceutical
11.5.1 Nanjing Xinbai Pharmaceutical Company Detail
11.5.2 Nanjing Xinbai Pharmaceutical Business Overview
11.5.3 Nanjing Xinbai Pharmaceutical CIS Insulin Introduction
11.5.4 Nanjing Xinbai Pharmaceutical Revenue in CIS Insulin Business (2018-2023)
11.5.5 Nanjing Xinbai Pharmaceutical Recent Development
11.6 Oramed Pharmaceuticals
11.6.1 Oramed Pharmaceuticals Company Detail
11.6.2 Oramed Pharmaceuticals Business Overview
11.6.3 Oramed Pharmaceuticals CIS Insulin Introduction
11.6.4 Oramed Pharmaceuticals Revenue in CIS Insulin Business (2018-2023)
11.6.5 Oramed Pharmaceuticals Recent Development
11.7 Merck
11.7.1 Merck Company Detail
11.7.2 Merck Business Overview
11.7.3 Merck CIS Insulin Introduction
11.7.4 Merck Revenue in CIS Insulin Business (2018-2023)
11.7.5 Merck Recent Development
11.8 Boehringer Ingelheim
11.8.1 Boehringer Ingelheim Company Detail
11.8.2 Boehringer Ingelheim Business Overview
11.8.3 Boehringer Ingelheim CIS Insulin Introduction
11.8.4 Boehringer Ingelheim Revenue in CIS Insulin Business (2018-2023)
11.8.5 Boehringer Ingelheim Recent Development
11.9 Biocon
11.9.1 Biocon Company Detail
11.9.2 Biocon Business Overview
11.9.3 Biocon CIS Insulin Introduction
11.9.4 Biocon Revenue in CIS Insulin Business (2018-2023)
11.9.5 Biocon Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global CIS Insulin Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Long-Acting Analog
Table 3. Key Players of Rapid Acting Analog
Table 4. Key Players of Premixed Analog
Table 5. Key Players of Intermediate Insulin
Table 6. Key Players of Short Acting Insulin
Table 7. Key Players of Premixed Insulin
Table 8. Global CIS Insulin Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 9. Global CIS Insulin Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 10. Global CIS Insulin Market Size by Region (2018-2023) & (US$ Million)
Table 11. Global CIS Insulin Market Share by Region (2018-2023)
Table 12. Global CIS Insulin Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 13. Global CIS Insulin Market Share by Region (2024-2033)
Table 14. CIS Insulin Market Trends
Table 15. CIS Insulin Market Drivers
Table 16. CIS Insulin Market Challenges
Table 17. CIS Insulin Market Restraints
Table 18. Global CIS Insulin Revenue by Players (2018-2023) & (US$ Million)
Table 19. Global CIS Insulin Market Share by Players (2018-2023)
Table 20. Global Top CIS Insulin Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CIS Insulin as of 2022)
Table 21. Ranking of Global Top CIS Insulin Companies by Revenue (US$ Million) in 2022
Table 22. Global 5 Largest Players Market Share by CIS Insulin Revenue (CR5 and HHI) & (2018-2023)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players CIS Insulin Product Solution and Service
Table 25. Date of Enter into CIS Insulin Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global CIS Insulin Market Size by Type (2018-2023) & (US$ Million)
Table 28. Global CIS Insulin Revenue Market Share by Type (2018-2023)
Table 29. Global CIS Insulin Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 30. Global CIS Insulin Revenue Market Share by Type (2024-2033)
Table 31. Global CIS Insulin Market Size by Application (2018-2023) & (US$ Million)
Table 32. Global CIS Insulin Revenue Market Share by Application (2018-2023)
Table 33. Global CIS Insulin Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 34. Global CIS Insulin Revenue Market Share by Application (2024-2033)
Table 35. North America CIS Insulin Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. North America CIS Insulin Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America CIS Insulin Market Size by Country (2024-2033) & (US$ Million)
Table 38. Europe CIS Insulin Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 39. Europe CIS Insulin Market Size by Country (2018-2023) & (US$ Million)
Table 40. Europe CIS Insulin Market Size by Country (2024-2033) & (US$ Million)
Table 41. Asia-Pacific CIS Insulin Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 42. Asia-Pacific CIS Insulin Market Size by Region (2018-2023) & (US$ Million)
Table 43. Asia-Pacific CIS Insulin Market Size by Region (2024-2033) & (US$ Million)
Table 44. Latin America CIS Insulin Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Latin America CIS Insulin Market Size by Country (2018-2023) & (US$ Million)
Table 46. Latin America CIS Insulin Market Size by Country (2024-2033) & (US$ Million)
Table 47. Middle East & Africa CIS Insulin Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 48. Middle East & Africa CIS Insulin Market Size by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa CIS Insulin Market Size by Country (2024-2033) & (US$ Million)
Table 50. Eli Lilly Company Detail
Table 51. Eli Lilly Business Overview
Table 52. Eli Lilly CIS Insulin Product
Table 53. Eli Lilly Revenue in CIS Insulin Business (2018-2023) & (US$ Million)
Table 54. Eli Lilly Recent Development
Table 55. Novo Nordisk Company Detail
Table 56. Novo Nordisk Business Overview
Table 57. Novo Nordisk CIS Insulin Product
Table 58. Novo Nordisk Revenue in CIS Insulin Business (2018-2023) & (US$ Million)
Table 59. Novo Nordisk Recent Development
Table 60. Takeda Pharmaceuticals Company Detail
Table 61. Takeda Pharmaceuticals Business Overview
Table 62. Takeda Pharmaceuticals CIS Insulin Product
Table 63. Takeda Pharmaceuticals Revenue in CIS Insulin Business (2018-2023) & (US$ Million)
Table 64. Takeda Pharmaceuticals Recent Development
Table 65. Sanofi Aventis Company Detail
Table 66. Sanofi Aventis Business Overview
Table 67. Sanofi Aventis CIS Insulin Product
Table 68. Sanofi Aventis Revenue in CIS Insulin Business (2018-2023) & (US$ Million)
Table 69. Sanofi Aventis Recent Development
Table 70. Nanjing Xinbai Pharmaceutical Company Detail
Table 71. Nanjing Xinbai Pharmaceutical Business Overview
Table 72. Nanjing Xinbai Pharmaceutical CIS Insulin Product
Table 73. Nanjing Xinbai Pharmaceutical Revenue in CIS Insulin Business (2018-2023) & (US$ Million)
Table 74. Nanjing Xinbai Pharmaceutical Recent Development
Table 75. Oramed Pharmaceuticals Company Detail
Table 76. Oramed Pharmaceuticals Business Overview
Table 77. Oramed Pharmaceuticals CIS Insulin Product
Table 78. Oramed Pharmaceuticals Revenue in CIS Insulin Business (2018-2023) & (US$ Million)
Table 79. Oramed Pharmaceuticals Recent Development
Table 80. Merck Company Detail
Table 81. Merck Business Overview
Table 82. Merck CIS Insulin Product
Table 83. Merck Revenue in CIS Insulin Business (2018-2023) & (US$ Million)
Table 84. Merck Recent Development
Table 85. Boehringer Ingelheim Company Detail
Table 86. Boehringer Ingelheim Business Overview
Table 87. Boehringer Ingelheim CIS Insulin Product
Table 88. Boehringer Ingelheim Revenue in CIS Insulin Business (2018-2023) & (US$ Million)
Table 89. Boehringer Ingelheim Recent Development
Table 90. Biocon Company Detail
Table 91. Biocon Business Overview
Table 92. Biocon CIS Insulin Product
Table 93. Biocon Revenue in CIS Insulin Business (2018-2023) & (US$ Million)
Table 94. Biocon Recent Development
Table 95. Research Programs/Design for This Report
Table 96. Key Data Information from Secondary Sources
Table 97. Key Data Information from Primary Sources
List of Figures
Figure 1. Global CIS Insulin Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global CIS Insulin Market Share by Type: 2022 VS 2033
Figure 3. Long-Acting Analog Features
Figure 4. Rapid Acting Analog Features
Figure 5. Premixed Analog Features
Figure 6. Intermediate Insulin Features
Figure 7. Short Acting Insulin Features
Figure 8. Premixed Insulin Features
Figure 9. Global CIS Insulin Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 10. Global CIS Insulin Market Share by Application: 2022 VS 2033
Figure 11. Type I and Other Diabetes Case Studies
Figure 12. Type II Diabetes Case Studies
Figure 13. CIS Insulin Report Years Considered
Figure 14. Global CIS Insulin Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 15. Global CIS Insulin Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 16. Global CIS Insulin Market Share by Region: 2022 VS 2033
Figure 17. Global CIS Insulin Market Share by Players in 2022
Figure 18. Global Top CIS Insulin Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CIS Insulin as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by CIS Insulin Revenue in 2022
Figure 20. North America CIS Insulin Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. North America CIS Insulin Market Share by Country (2018-2033)
Figure 22. United States CIS Insulin Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Canada CIS Insulin Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe CIS Insulin Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Europe CIS Insulin Market Share by Country (2018-2033)
Figure 26. Germany CIS Insulin Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. France CIS Insulin Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. U.K. CIS Insulin Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Italy CIS Insulin Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Russia CIS Insulin Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Nordic Countries CIS Insulin Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific CIS Insulin Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Asia-Pacific CIS Insulin Market Share by Region (2018-2033)
Figure 34. China CIS Insulin Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Japan CIS Insulin Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. South Korea CIS Insulin Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Southeast Asia CIS Insulin Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. India CIS Insulin Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Australia CIS Insulin Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America CIS Insulin Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Latin America CIS Insulin Market Share by Country (2018-2033)
Figure 42. Mexico CIS Insulin Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Brazil CIS Insulin Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa CIS Insulin Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Middle East & Africa CIS Insulin Market Share by Country (2018-2033)
Figure 46. Turkey CIS Insulin Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Saudi Arabia CIS Insulin Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Eli Lilly Revenue Growth Rate in CIS Insulin Business (2018-2023)
Figure 49. Novo Nordisk Revenue Growth Rate in CIS Insulin Business (2018-2023)
Figure 50. Takeda Pharmaceuticals Revenue Growth Rate in CIS Insulin Business (2018-2023)
Figure 51. Sanofi Aventis Revenue Growth Rate in CIS Insulin Business (2018-2023)
Figure 52. Nanjing Xinbai Pharmaceutical Revenue Growth Rate in CIS Insulin Business (2018-2023)
Figure 53. Oramed Pharmaceuticals Revenue Growth Rate in CIS Insulin Business (2018-2023)
Figure 54. Merck Revenue Growth Rate in CIS Insulin Business (2018-2023)
Figure 55. Boehringer Ingelheim Revenue Growth Rate in CIS Insulin Business (2018-2023)
Figure 56. Biocon Revenue Growth Rate in CIS Insulin Business (2018-2023)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed